EE200200111A - Kondenseerunud pürroolkarboksamiidid: aju GABA-retseptori ligandid - Google Patents
Kondenseerunud pürroolkarboksamiidid: aju GABA-retseptori ligandidInfo
- Publication number
- EE200200111A EE200200111A EEP200200111A EEP200200111A EE200200111A EE 200200111 A EE200200111 A EE 200200111A EE P200200111 A EEP200200111 A EE P200200111A EE P200200111 A EEP200200111 A EE P200200111A EE 200200111 A EE200200111 A EE 200200111A
- Authority
- EE
- Estonia
- Prior art keywords
- receptor ligands
- gaba receptor
- brain gaba
- condensed pyrrole
- pyrrole carboxamides
- Prior art date
Links
- RLOQBKJCOAXOLR-UHFFFAOYSA-N 1h-pyrrole-2-carboxamide Chemical class NC(=O)C1=CC=CN1 RLOQBKJCOAXOLR-UHFFFAOYSA-N 0.000 title 1
- 102000005915 GABA Receptors Human genes 0.000 title 1
- 108010005551 GABA Receptors Proteins 0.000 title 1
- 210000004556 brain Anatomy 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0468—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K51/047—Benzodiazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70571—Assays involving receptors, cell surface antigens or cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38731199A | 1999-08-31 | 1999-08-31 | |
| US15178999P | 1999-08-31 | 1999-08-31 | |
| PCT/US2000/023862 WO2001016103A1 (en) | 1999-08-31 | 2000-08-30 | Fused pyrrolecarboxamides: gaba brain receptor ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200200111A true EE200200111A (et) | 2003-06-16 |
Family
ID=26848974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200200111A EE200200111A (et) | 1999-08-31 | 2000-08-30 | Kondenseerunud pürroolkarboksamiidid: aju GABA-retseptori ligandid |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7109351B1 (pt) |
| EP (1) | EP1210328A1 (pt) |
| JP (1) | JP2003508385A (pt) |
| KR (1) | KR20020027613A (pt) |
| CN (1) | CN1372546A (pt) |
| AP (1) | AP2002002420A0 (pt) |
| AU (1) | AU7092800A (pt) |
| BG (1) | BG106459A (pt) |
| BR (1) | BR0013664A (pt) |
| CA (1) | CA2381553A1 (pt) |
| CR (1) | CR6581A (pt) |
| CZ (1) | CZ2002614A3 (pt) |
| EA (1) | EA200200188A1 (pt) |
| EE (1) | EE200200111A (pt) |
| HR (1) | HRP20020104A2 (pt) |
| HU (1) | HUP0202534A3 (pt) |
| IL (1) | IL147971A0 (pt) |
| IS (1) | IS6290A (pt) |
| MX (1) | MXPA02001709A (pt) |
| NO (1) | NO20020948L (pt) |
| OA (1) | OA12015A (pt) |
| PL (1) | PL354513A1 (pt) |
| SK (1) | SK2582002A3 (pt) |
| TR (1) | TR200200544T2 (pt) |
| WO (1) | WO2001016103A1 (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050014939A1 (en) * | 1999-08-31 | 2005-01-20 | Neurogen Corporation | Fused pyrrolecarboxamides: GABA brain receptor ligands |
| AU2001241512A1 (en) * | 2000-03-13 | 2001-09-24 | Eli Lilly And Company | Sulfonamide derivatives |
| AU2001264932A1 (en) * | 2000-05-26 | 2001-12-11 | Neurogen Corporation | Oxo-imidazopyrimidine-carboxamides and their use as gaba brain receptor ligands |
| EP1326831A1 (en) * | 2000-09-06 | 2003-07-16 | Neurogen Corporation | Substituted fused pyrroleimines and pyrazoleimines |
| WO2002020492A1 (en) * | 2000-09-06 | 2002-03-14 | Neurogen Corporation | Aryl substituted tetrahydroindazoles and their use as ligands for the gaba-a receptor |
| US6861529B2 (en) * | 2001-07-06 | 2005-03-01 | Pfizer Inc | Cycloalkypyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives |
| JP2005525333A (ja) | 2002-02-07 | 2005-08-25 | ニューロジェン コーポレイション | 置換縮合ピラゾールカルボン酸アリールアミド及び関連化合物 |
| WO2005016928A1 (ja) * | 2003-08-15 | 2005-02-24 | Banyu Pharmaceutical Co., Ltd. | イミダゾピリジン誘導体 |
| WO2005030148A2 (en) | 2003-09-25 | 2005-04-07 | Cenomed, Inc. | Tetrahydroindolone derivatives for treatment of neurological conditions |
| CA2566184A1 (en) * | 2004-05-10 | 2005-11-17 | Banyu Pharmaceutical Co., Ltd. | Imidazopyridine compound |
| US20080275112A1 (en) * | 2004-07-23 | 2008-11-06 | Schreiner Peter R | Invention Concerning Aminoadamantane Compounds |
| EA201300152A1 (ru) * | 2006-11-27 | 2013-07-30 | Х. Лундбекк А/С | Гетероариламидные производные |
| WO2009075874A1 (en) * | 2007-12-13 | 2009-06-18 | Amgen Inc. | Gamma secretase modulators |
| US8455477B2 (en) * | 2008-08-05 | 2013-06-04 | Merck Sharp & Dohme Corp. | Therapeutic compounds |
| US20150374705A1 (en) | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3455943A (en) | 1966-10-21 | 1969-07-15 | American Cyanamid Co | Certain 5,8-dihydro-beta-carbolines |
| US4075343A (en) | 1976-09-13 | 1978-02-21 | Pfizer Inc. | Anti-allergenic 5-alkoxyimidazo[1,2-A]quinoline-2-carboxylic acids and derivatives thereof |
| DE3029980A1 (de) | 1980-08-08 | 1982-03-11 | Boehringer Mannheim Gmbh, 6800 Mannheim | Indolderivate und verfahren zu ihrer herstellung |
| JPS57123180A (en) | 1980-12-17 | 1982-07-31 | Schering Ag | 3-substituted beta-carboline, manufacture and psychotropic drug containing same |
| DE3147276A1 (de) | 1981-11-28 | 1983-06-09 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur herstellung von indolderivaten, deren verwendung als wertvolle zwischenprodukte und neue 4-hydroxyindole |
| DE3246932A1 (de) | 1982-12-16 | 1984-06-20 | Schering AG, 1000 Berlin und 4709 Bergkamen | Substituierte 5h-pyrimido(5,4-b)indole |
| DE3335323A1 (de) | 1983-09-27 | 1985-04-04 | Schering AG, 1000 Berlin und 4709 Bergkamen | Substituierte ss-carboline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| GB8429739D0 (en) | 1984-11-24 | 1985-01-03 | Fbc Ltd | Fungicides |
| DE3535927A1 (de) | 1985-10-04 | 1987-04-09 | Schering Ag | 3-vinyl- und 3-ethinyl-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel |
| CA2091986C (en) | 1990-10-09 | 1995-11-28 | Andrew Thurkauf | Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of gaba brain receptor ligands |
| US5243049A (en) | 1992-01-22 | 1993-09-07 | Neurogen Corporation | Certain pyrroloquinolinones: a new class of GABA brain receptor ligands |
| AU3443493A (en) | 1992-02-19 | 1993-09-13 | Upjohn Company, The | 3-substituted imidazo(1,5-a)quinoxalines and quinazolines with cns activity |
| US5266698A (en) | 1992-04-30 | 1993-11-30 | Neurogen Corporation | Certain aryl and cycloalkyl fused imidazopyrazinediones; a new class of GABA brain receptor ligands |
| WO1994017095A1 (en) | 1993-01-29 | 1994-08-04 | Ariad Pharmaceuticals, Inc. | Analogs of receptor tyrosine activation motifs and therapeutic uses thereof |
| US5750702A (en) * | 1993-10-27 | 1998-05-12 | Neurogen Corporation | Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands |
| US5484944A (en) * | 1993-10-27 | 1996-01-16 | Neurogen Corporation | Certain fused pyrrolecarboxanilides and their use as GABA brain receptor ligands |
| US5804686A (en) | 1996-01-19 | 1998-09-08 | Neurogen Corporation | fused pyrrolecarboxamides; a new class of GABA brain receptor ligands |
| US6211365B1 (en) * | 1996-01-19 | 2001-04-03 | Neurogen Corporation | Fused pyrrolecarboxamides; a new class of GABA brain receptor ligands |
| IT1287264B1 (it) * | 1996-03-21 | 1998-08-04 | Lino Crespan | Freno perfezionato per pattini con ruote in linea |
| US5677309A (en) | 1996-03-22 | 1997-10-14 | Neurogen Corporation | 1,2,4-triazolo 4,3-c! quinazolin-3-ones and 1,2,4-triazolo 4,3-c!quinazolin-3-thiones; a new class of GABA brain receptor ligands |
| US5955465A (en) | 1996-03-22 | 1999-09-21 | Neurogen Corporation | 1,2,4-triazolo 4,3-c!quinazolin-3-ones and 1,2,4-triazolo 4,3-c!quinazolin-3-thiones |
| WO1997034870A1 (en) * | 1996-03-22 | 1997-09-25 | Neurogen Corporation | Certain fused pyrrolecarboxamides as gaba brain receptor ligands |
| US5723462A (en) | 1996-04-26 | 1998-03-03 | Neurogen Corporation | Certain fused pyrrolecarboxamides a new class of GABA brain receptor ligands |
| YU27300A (sh) * | 1997-11-13 | 2002-10-18 | Pfizer Products Inc. | Postupak sinteze pirolnih amida |
-
2000
- 2000-08-30 CZ CZ2002614A patent/CZ2002614A3/cs unknown
- 2000-08-30 AU AU70928/00A patent/AU7092800A/en not_active Abandoned
- 2000-08-30 PL PL00354513A patent/PL354513A1/xx not_active Application Discontinuation
- 2000-08-30 JP JP2001519673A patent/JP2003508385A/ja not_active Withdrawn
- 2000-08-30 EP EP00959643A patent/EP1210328A1/en not_active Withdrawn
- 2000-08-30 IL IL14797100A patent/IL147971A0/xx unknown
- 2000-08-30 AP APAP/P/2002/002420A patent/AP2002002420A0/en unknown
- 2000-08-30 CN CN00812233A patent/CN1372546A/zh active Pending
- 2000-08-30 MX MXPA02001709A patent/MXPA02001709A/es active IP Right Grant
- 2000-08-30 OA OA1200200063A patent/OA12015A/en unknown
- 2000-08-30 CA CA002381553A patent/CA2381553A1/en not_active Abandoned
- 2000-08-30 TR TR2002/00544T patent/TR200200544T2/xx unknown
- 2000-08-30 KR KR1020027002757A patent/KR20020027613A/ko not_active Application Discontinuation
- 2000-08-30 BR BR0013664-6A patent/BR0013664A/pt not_active Application Discontinuation
- 2000-08-30 EE EEP200200111A patent/EE200200111A/xx unknown
- 2000-08-30 US US09/651,207 patent/US7109351B1/en not_active Expired - Fee Related
- 2000-08-30 EA EA200200188A patent/EA200200188A1/ru unknown
- 2000-08-30 WO PCT/US2000/023862 patent/WO2001016103A1/en not_active Application Discontinuation
- 2000-08-30 SK SK258-2002A patent/SK2582002A3/sk unknown
- 2000-08-30 HU HU0202534A patent/HUP0202534A3/hu unknown
-
2002
- 2002-02-01 HR HR20020104A patent/HRP20020104A2/hr not_active Application Discontinuation
- 2002-02-07 CR CR6581A patent/CR6581A/es not_active Application Discontinuation
- 2002-02-27 IS IS6290A patent/IS6290A/is unknown
- 2002-02-27 NO NO20020948A patent/NO20020948L/no unknown
- 2002-02-28 BG BG106459A patent/BG106459A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US7109351B1 (en) | 2006-09-19 |
| SK2582002A3 (en) | 2003-02-04 |
| KR20020027613A (ko) | 2002-04-13 |
| IS6290A (is) | 2002-02-27 |
| TR200200544T2 (tr) | 2002-06-21 |
| CZ2002614A3 (cs) | 2002-08-14 |
| IL147971A0 (en) | 2002-09-12 |
| HUP0202534A3 (en) | 2002-12-28 |
| CR6581A (es) | 2004-03-31 |
| MXPA02001709A (es) | 2002-10-23 |
| NO20020948L (no) | 2002-02-28 |
| AU7092800A (en) | 2001-03-26 |
| CA2381553A1 (en) | 2001-03-08 |
| JP2003508385A (ja) | 2003-03-04 |
| NO20020948D0 (no) | 2002-02-27 |
| EP1210328A1 (en) | 2002-06-05 |
| PL354513A1 (en) | 2004-01-26 |
| EA200200188A1 (ru) | 2002-08-29 |
| CN1372546A (zh) | 2002-10-02 |
| WO2001016103A1 (en) | 2001-03-08 |
| BG106459A (bg) | 2002-12-29 |
| HUP0202534A2 (hu) | 2002-11-28 |
| AP2002002420A0 (en) | 2002-03-31 |
| BR0013664A (pt) | 2002-05-14 |
| HRP20020104A2 (en) | 2004-02-29 |
| OA12015A (en) | 2006-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200200111A (et) | Kondenseerunud pürroolkarboksamiidid: aju GABA-retseptori ligandid | |
| NO20015613D0 (no) | Fremgangsmåte for polymerisasjon | |
| MA25403A1 (fr) | Ligandes de recepteur de melanocortine | |
| ID29399A (id) | Proses polimerisasi | |
| DE60007050D1 (de) | IMC-Verfahren | |
| DK1165576T3 (da) | Fremgangsmåde til fremstilling af amin-platin-komplekser | |
| ID27308A (id) | Proses aksidasi | |
| ID28724A (id) | Proses untuk memproduksi sikloalkanon | |
| NO20013997D0 (no) | Reseptoranalyse | |
| NO20000822D0 (no) | Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorligander | |
| ID29787A (id) | Proses untuk memproduksi cairan kaya-metana | |
| DK1210318T3 (da) | Fremgangsmåde til fremstilling af adrenalin | |
| ID25662A (id) | Proses kontinyu untuk memproduksi poliamida dari aminonitril | |
| ID26278A (id) | Proses pembuatan sertralina dari kiral tetralon | |
| DE60009063D1 (de) | Liganden für den ip3 rezeptor | |
| IT1318913B1 (it) | Imbuto per velo | |
| NO20021295D0 (no) | Nikotinsyreacetylcholin-reseptor | |
| ID27404A (id) | Proses asilasi | |
| ID26021A (id) | Proses untuk menyiapan 1h-indole-3-glioksamida disubstitusi-4 1h-indole-glioksamida disubstitusi-4 | |
| DE60001315D1 (de) | Verteilervorrichtung | |
| ID30126A (id) | METODE UNTUK MENGHASILKAN SIKLO-(Asp-DPhe-NMeVal-Arg-Gly) | |
| FR2822900B1 (fr) | Procede de rechauffement d'un catalyseur | |
| ID25428A (id) | Proses untk pembuatan tioamida siklis | |
| FI990674A0 (fi) | Menetelmä polymeerien valmistamiseksi | |
| ID30517A (id) | Proses untuk menyiapkan melamin padat |